Delivery Order SPE2DB25D3201-SPE2DB25FNTFP

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a ceiling value of $3,472.02 and a period of performance through May 8, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $3,162.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product, with a period of performance through February 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FERAHEME 510 MG/17 ML VIAL 17ML. The contract has a ceiling value of $3,856.10 and a performance period ending on June 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a $3,470.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568318214 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of May 22, 2025 and is not set aside. AmerisourceBergen Drug Corp is a critical supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the military healthcare system,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a ceiling value of $2,666.12 and a performance period ending on June 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,183.21, is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a ceiling value of $3,665.15 and a performance period ending on July 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a ceiling value of $4,290.25. The contract has a period of performance through June 25, 2025 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $39,043.60 contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a ceiling value of $2,199.52 and a performance period ending on May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTFP
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has a ceiling value of $3,390.46 and an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/17/25, 1:25 AM